Related Experiment Videos
Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia
Carla M Wood1, Patricia A Goodman, Faith M Uckun
1Department of Molecular Genetics, Parker Hughes Cancer Center, Parker Hughes Institute, 2699 Patton Road, St Paul, MN 55113, USA.
Leukemia & Lymphoma
|March 5, 2003
Summary
This study corrects the genomic sequence of the Janus tyrosine kinase 3 (JAK3) gene, specifically introns 10 and 11, revealing novel elements and improving accuracy for JAK3 gene expression analysis in acute lymphoblastic leukemia (ALL).
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Background:
- Janus tyrosine kinase 3 (JAK3) is a critical enzyme in B-cell precursor regulation, with elevated activity linked to drug resistance in acute lymphoblastic leukemia (ALL).
- Accurate genomic sequencing of JAK3 is essential for understanding its role in pediatric ALL.
- Previous genomic data for JAK3, particularly introns 10 and 11, contained inaccuracies.
Purpose of the Study:
- To systematically determine the accurate genomic sequence of a specific region of the JAK3 gene, including introns 10 and 11.
- To identify any discrepancies or novel elements within this JAK3 genomic region.
- To refine the understanding of JAK3 gene expression in pediatric ALL.
Main Methods:
- Sequencing of a JAK3 genomic region spanning introns 10 and 11.
- Analysis of RT-PCR products from primary pediatric and infant ALL cells.
- Bioinformatic analysis to identify sequence homology, including repetitive elements and potential single nucleotide polymorphisms (SNPs).
Main Results:
- A previously unreported gap in the JAK3 genomic sequence within intron 10, corresponding to an Alu element, was identified.
- The sequence of intron 11 was found to be significantly different and longer (1.1 kb) than previously reported, containing Alu and LINE2 elements.
- Two potential SNPs were detected in intron 11; no mutations specific to ALL were found in the examined region.
Conclusions:
- The study provides a corrected and more accurate genomic sequence for a critical region of the JAK3 gene.
- These findings resolve discrepancies in existing JAK3 genomic data, crucial for accurate gene expression studies in ALL.
- The corrected sequence extends the genomic knowledge of JAK3 and aids in understanding its role in childhood pro-B ALL.